{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T15:26:51Z","timestamp":1791732411859,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017633","name":"Shanghai Anti-Cancer Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372883"],"award-info":[{"award-number":["82372883"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2022YFB4700904"],"award-info":[{"award-number":["2022YFB4700904"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.drup.2026.101388","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:55:27Z","timestamp":1773161727000},"page":"101388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Endothelial SMAD1-MCAM axis facilitates sunitinib resistance and progression of clear cell renal cell carcinoma via LAMB1-ITGB1 signaling"],"prefix":"10.1016","volume":"86","author":[{"given":"Hanzhong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangzheqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6070-1832","authenticated-orcid":false,"given":"Linhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.drup.2026.101388_bib1","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1038\/s41388-020-01444-3","article-title":"Inactivation of endothelial cell phosphoinositide 3-kinase \u03b2 inhibits tumor angiogenesis and tumor growth","volume":"39","author":"Azad","year":"2020","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.drup.2026.101388_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1158\/1078-0432.CCR-14-1128","article-title":"Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting","volume":"21","author":"Beuselinck","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.drup.2026.101388_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ccr.2012.11.009","article-title":"EMT and MET in metastasis: where are the cancer stem cells?","volume":"22","author":"Brabletz","year":"2012","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.drup.2026.101388_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/s41592-023-01938-4","article-title":"SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks","volume":"20","author":"Bravo Gonz\u00e1lez-Blas","year":"2023","journal-title":"Nat. Methods"},{"issue":"10","key":"10.1016\/j.drup.2026.101388_bib5","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1093\/bioinformatics\/btaa099","article-title":"GeneSwitches: ordering gene expression and functional events in single-cell experiments","volume":"36","author":"Cao","year":"2020","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.drup.2026.101388_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ijc.35181","article-title":"New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities","volume":"156","author":"Cesana","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2026.101388_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib8","first-page":"136","article-title":"Systematic investigation of tumor microenvironment and antitumor immunity with IOBR","volume":"1","author":"Fang","year":"2025","journal-title":"Med. Res."},{"issue":"6476","key":"10.1016\/j.drup.2026.101388_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.aax0249","article-title":"Single-cell transcriptional diversity is a hallmark of developmental potential","volume":"367","author":"Gulati","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib10","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"issue":"13","key":"10.1016\/j.drup.2026.101388_bib11","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.drup.2026.101388_bib12","article-title":"Targeted therapy for metastatic renal cell carcinoma","volume":"10","author":"Hofmann","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib14","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/s41467-020-15816-6","article-title":"Accurate estimation of cell composition in bulk expression through robust integration of single-cell information","volume":"11","author":"Jew","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.drup.2026.101388_bib15","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1097\/JS9.0000000000001377","article-title":"Urological surgical robot in China: state of the art and future prospect","volume":"110","author":"Jiang","year":"2024","journal-title":"Int. J. Surg."},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2024.04.001","article-title":"Re: multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression","volume":"86","author":"Jiang","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.drup.2026.101388_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2019.10.013","article-title":"Communication between EMT and PD-L1 signaling: new insights into tumor immune evasion","volume":"468","author":"Jiang","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101388_bib19","article-title":"Sunitinib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers","volume":"67","author":"Jin","year":"2023","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"12","key":"10.1016\/j.drup.2026.101388_bib20","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"issue":"45","key":"10.1016\/j.drup.2026.101388_bib21","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2024.39.e293","article-title":"Sites of metastasis and survival in metastatic renal cell carcinoma: results From the Korean renal cancer study group database","volume":"39","author":"Lee","year":"2024","journal-title":"J. Korean Med. Sci."},{"issue":"8","key":"10.1016\/j.drup.2026.101388_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00018-022-04420-0","article-title":"CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling","volume":"79","author":"Liang","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.drup.2026.101388_bib23","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1101\/gr.276851.122","article-title":"Scalable and model-free detection of spatial patterns and colocalization","volume":"32","author":"Liu","year":"2022","journal-title":"Genome Res"},{"issue":"39","key":"10.1016\/j.drup.2026.101388_bib24","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1038\/s41388-020-01428-3","article-title":"ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101388_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102377","article-title":"New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: a systematic review and network meta-analysis","volume":"106","author":"Lombardi","year":"2022","journal-title":"Cancer Treat. Rev."},{"issue":"43","key":"10.1016\/j.drup.2026.101388_bib26","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.drup.2026.101388_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2018.05.016","article-title":"CD146 mediates an E-cadherin-to-N-cadherin switch during TGF-\u03b2 signaling-induced epithelial-mesenchymal transition","volume":"430","author":"Ma","year":"2018","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.drup.2026.101388_bib28","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/s44321-025-00288-2","article-title":"Understanding cancer cell plasticity: EMT, respecialisation, and therapeutic opportunities","volume":"17","author":"Morel","year":"2025","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.drup.2026.101388_bib29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ccell.2020.10.011","article-title":"Molecular subsets in renal cancer determacine outcome to checkpoint and angiogenesis blockade","volume":"38","author":"Motzer","year":"2020","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.drup.2026.101388_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","article-title":"Squidpy: a scalable framework for spatial omics analysis","volume":"19","author":"Palla","year":"2022","journal-title":"Nat. Methods"},{"issue":"8024","key":"10.1016\/j.drup.2026.101388_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07698-1","article-title":"Tumour vasculature at single-cell resolution","volume":"632","author":"Pan","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib32","article-title":"Kidney cancer: From tumor biology to innovative therapeutics","volume":"1880","author":"Rinaldi","year":"2025","journal-title":"Biochim. et Biophys. Acta (BBA) Rev. Cancer"},{"issue":"10189","key":"10.1016\/j.drup.2026.101388_bib33","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/S0140-6736(19)30723-8","article-title":"Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial","volume":"393","author":"Rini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2026.101388_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104978","article-title":"Adjuvant immunotherapy in high-risk renal cell carcinoma: indications, limitations, and perspectives. A consensus statement from the GIOTTO uro-oncology group","volume":"216","author":"Roviello","year":"2025","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"2","key":"10.1016\/j.drup.2026.101388_bib35","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_430734","article-title":"Update on biomarkers in renal cell carcinoma","volume":"44","author":"Saliby","year":"2024","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"0","key":"10.1016\/j.drup.2026.101388_bib36","article-title":"Postimmunotherapy and vascular endothelial growth factor inhibitor landscape in advanced renal cell carcinoma: treatment patterns, costs, and outcomes","volume":"0","author":"Shah","year":"2025","journal-title":"JCO Oncol. Pract."},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib37","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"7828","key":"10.1016\/j.drup.2026.101388_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-020-2774-y","article-title":"Tumoural activation of TLR3\u2013SLIT2 axis in endothelium drives metastasis","volume":"586","author":"Tavora","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.drup.2026.101388_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54246-6","article-title":"Loss of NUMB drives aggressive bladder cancer via a RHOA\/ROCK\/YAP signaling axis","volume":"15","author":"Tucci","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.drup.2026.101388_bib41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41419-025-07444-z","article-title":"Tumor vascular endothelial cells promote immune escape by upregulating PD-L1 expression via crosstalk between NF-\u03baB and STAT3 signaling pathways in nasopharyngeal carcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s40364-025-00811-0","article-title":"Single-cell sequencing technology in renal cancer: insights into tumor biology and clinical application","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101388_bib44","first-page":"131","article-title":"GseaVis: an R package for enhanced visualization of gene set enrichment analysis in biomedicine","volume":"1","author":"Zhang","year":"2025","journal-title":"Med. Res."},{"issue":"12","key":"10.1016\/j.drup.2026.101388_bib45","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1111\/cas.15551","article-title":"SAR1A regulates the RhoA\/YAP and autophagy signaling pathways to influence osteosarcoma invasion and metastasis","volume":"113","author":"Zhan","year":"2022","journal-title":"Cancer Sci."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:27:11Z","timestamp":1781825231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"alternative-id":["S1368764626000397"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101388","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial SMAD1-MCAM axis facilitates sunitinib resistance and progression of clear cell renal cell carcinoma via LAMB1-ITGB1 signaling","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101388"}}